Alexis Gilroy, a national leader in the digital health industry, advises on complex transactional and health regulatory issues with an emphasis on virtual health methods and tools, such as, telemedicine, telehealth, and mobile health.
Focused on transactions in the digital health and HIT sectors for more than a decade, Alexis pairs practical experience with a keen understanding of often novel federal and multi-jurisdictional state regulatory requirements. Hospitals, health systems and other health providers, virtual health companies, technology organizations, e-commerce, pharmacy and retail leaders, life science businesses, and investors from across the US seek her legal counsel on various e-health topics, including multi-jurisdictional business strategy and implementation, state-specific telehealth regulation, corporate practice of medicine, reimbursement, international second opinion and telehealth programs, online prescribing, patient consent, credentialing by proxy, remote supervision, and fraud & abuse considerations. Alexis frequently develops and negotiates telehealth specific services and affiliation contracts and manages health regulatory matters for M&A and equity transactions with both investor/buy-side and company/target-side experience.
Alexis speaks and writes extensively on matters involving digital health, including testimony before legislative and regulatory bodies. She serves on the board of directors of the American Telemedicine Association and as Co-Chair of the ClearHealth Quality Institute Telemedicine Accreditation Standards Committee. She was previously an appointee to the Maryland Governor’s Telemedicine Taskforce, member of the Federation of State Medical Boards’ workgroup on telehealth, leader of the American Bar Association’s Science & Technology Practice Group, and leader of the American Health Lawyer Association’s E-Health and Telemedicine Affinity Group.